tbuckley/cabot-search huggingface dataset:
Khirurgiia, Moscow
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Long-Term in Vivo Carcinogenicity Tests of Potassium Bromate, Sodium Hypochlorite, and Sodium Chlorite Conducted in Japan
Authors: Yuji Kurokawa, Shozo Takayama, Yoichi Konishi, Yoshio Hiasa, Shogo Asahina, Michihito Takahashi, Akihiko Maekawa, Yuzo Hayashi
Journal: Environmental Health Perspectives (1986)

Long-term in vivo carcinogenicity tests of potassium bromate (KBrO3), sodium hypochlorite (NaClO), and sodium chlorite (NaClO2) have been conducted in Japan from 1977 to 1985. In these investigations, groups of approximately 50 male and 50 female F344 rats or B6C3F1 mice were given solutions of the compounds as their drinking water ad libitum at two dose levels determined on the basis of preliminary 13-week tests. Control animals were given distilled water. The carcinogenic potential of KBrO3 was tested by administering doses of 500 or 250 ppm to rats for 110 weeks. Significantly elevated incidences of renal cell tumors in males and females and mesotheliomas of the peritoneum in males as compared to controls were observed. When female mice were given KBrO3 at doses of 1000 or 500 ppm for 78 weeks, no significant differences in tumor incidences between experimental and control groups were apparent. NaClO was administered to male and female rats, respectively, at doses of 1000 or 500 ppm and 2000 or 1000 ppm for 104 weeks. In mice, NaClO was given at doses of 1000 or 500 ppm to either sex for 103 weeks. The incidences of tumors in NaClO-treated and control animals of both sexes were not significantly different in both rat and mouse studies. NaClO2 was given to rats of both sexes at a dose of 600 or 300 ppm for 85 weeks. No statistically significant differences were observed in the incidences of tumor formation between NaClO2-treated and control groups of both sexes. NaClO2 was administered to mice at a concentration of 500 or 250 ppm for 85 weeks. In males, the combined incidences of hyperplastic nodules and hepatocellular carcinomas of the liver in a low-dose group, and adenomas and adenocarcinomas of the lung in a high-dose group, were marginally increased compared to controls (p less than 0.05). However, these incidences in treated males were within the range of values of historical control data in our program. We concluded that KBrO3 was carcinogenic in rats of both sexes. NaClO was not carcinogenic in either rats and or mice under the conditions of the present studies. Although NaClO2 was shown to be noncarcinogenic in rats, the results for mice were evaluated as inconclusive. Also the results of two-stage mouse skin carcinogenesis using KBrO3, NaClO, and NaClO2 are presented. The necessity for further testing of oxidant chemicals to determine potential carcinogenic and/or promoting effects is suggested in view of the recently proposed role of active oxygen species in carcinogenesis.
NEW ANESTHETICS: ETHYLENE AND ACETYLENE
Journal: JAMA (1923)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
SYPHILIS IN ANTHROPOIDS.
Journal: JAMA (1904)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Valid Objections to So-called Christian Science.
Journal: JAMA (1902)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Eye findings in the diagnosis of Fabry's disease. Patients with renal failure
Authors: S. E. Bloomfield
Journal: JAMA (1978)

Two patients underwent renal transplantation for what was thought to be glomerulonephritis and chronic pyelonephritis. The diagnosis of Fabry's disease was made as an incidental finding during an ophthalmologic consultation for evaluation of blurred vision. These two cases illustrate the usefulness of an eye examination in the correct diagnosis in patients with the multisystem complaints of Fabry's disease. The correct diagnosis was extremely important in understanding the other manifestations of this disease in the affected patient and in the genetic counseling of the family. (<i>JAMA</i>240:647-649, 1978)
298O The clinical significance of deregulated cyclin E1 in high grade serous ovarian cancer (HGSOC)
Authors: D. Aziz, D. Etemadmoghadam, G. Au-Yeung, A. Muranyi, I. Gresshoff, M. Christie, R.A. Hutchinson, D. Ferraro, S. Stanislaw, L.A. Henricksen, A. Tubbs, K. Shanmugam, D. Bowtell, P.M. Waring
Journal: Annals of Oncology (2016)
Tablet Medication.
Authors: William L. Baum
Journal: JAMA (1896)

Chicago, Nov. 18, 1896. <h3>To the Editor:</h3> —I have read with considerable interest an article appearing in theJournal of the American Medical Association, issue of October 31, under the above title. Our particular attention is drawn to a statement which reads as follows: "A very large proportion of the pharmacopeia is made up of substances which can very readily be made into tablets." In looking through the list of about 1,000 official products eligible for a medicinal administration, we find between eighty and ninety which are suitable for this mode of administration without suffering loss of therapeutic value by manipulation, and a great portion of this number being powdered drugs, such as blue flag, snake root, buchu, etc., which are seldom, if ever, used in tablet form, being almost always represented by the extract. Possibly if the writer of the article in question had investigated the subject fully he would
Pseudomonas Exotoxin Shock
Authors: Mohammad Atik
Journal: JAMA (1968)

A study of shock following infusion of a newly described exotoxin from<i>Pseudomonas aeruginosa</i>(strain P-A-103) in the dog demonstrated two types of reactions: an immediate anaphylactoid reaction from which the dogs usually recovered, and a late hypotensive reaction which persisted and slowly progressed to death in 24 hours in all six of the untreated dogs. The circulatory and certain biochemical changes studied with this exotoxin shock were similar to those observed with endotoxin shock. Pretreatment with saline in five dogs and with nonimmune serum in eight dogs offered no significant protection. Pretreatment with dextran 40 minimized the anaphylactoid reaction but did not provide significant protection against ultimate death. Pretreatment with specific immune serum resulted in survival of all six dogs infused with the exotoxin but did not reduce the severity of transient anaphylactoid reaction.
Foreword
Authors: Peter Siersema
Journal: Endoscopy (2013)

2013 was a time of change in our journal. Mid-year, Thomas Rösch handed the reigns to me in the role of Editor-in-Chief and I was joined by Mario Dinis-Ribeiro and Michael Bretthauer as Co-Editors-in-Chief. Our core team of Co-Editors remained on board and has since been enhanced by Klaus Mönkemüller (USA) and Marcin Polkowski (Poland). They have brought further new ideas and impetus and our journal is greatly benefiting from their contribution. We will be saying good-bye to one Co-Editor who has been in our team since 2006, Kenjiro Yasuda, and I would like to take the opportunity to thank him here for all he has done for Endoscopy.
Rewording of Conclusions and Corrected Data in Table 1
Journal: JAMA Internal Medicine (2018)

Julia Baudry, PhD; Karen E. Assmann, PhD; Mathilde Touvier, PhD; Benjamin Allès, PhD; Louise Seconda, MSc; Paule Latino-Martel, PhD; Khaled Ezzedine, MD, PhD; Pilar Galan, MD, PhD; Serge Hercberg, MD, PhD; Denis Lairon, PhD; Emmanuelle Kesse-Guyot, PhD
Diseases of the Gastrointestinal Tract
Authors: J C Cain, R A Rovelstad
Journal: Annual Review of Medicine (1956)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), emerged in China in December 2019 and quickly spread around the globe, killing more than 4 million people and causing a severe economic crisis. ...Read More
MISSOURI'S CHIEF EXECUTIVE.
Journal: JAMA (1901)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
ABSTRACTS
Authors: H Si'aer, John Bateman, Jozef Jerzy, T Bothwell, Af Riea ', ' Brittingham, J Chatterjea, Amos Chernoff, Tenu Degruchy, Pietro Austrahi', A Erslev, Katsuhiro Fukutake, C Guardamagria, N Massari, C Santambrogio, L Lenzerini, L Contu, A Haheeb, D Smith, I Prystowsky, A Jiellegers, P Brims, B Topor, B1 Ahels, I Vegter, M Woldring, I Hans, H Niewcg, J Soulier
Journal: Blood (1960)
I Hope
Authors: Jill D. Kremer
Journal: JAMA Oncology (2015)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Oncology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Oncology journal
Rheumatic Fever in New Haven
Journal: JAMA (1942)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Supervoltage irradiation. Prophylactic vs therapeutic use for transitional cell carcinoma of the bladder, group I
Authors: F. Buschke
Journal: JAMA (1968)

Based on my personal experience with supervoltage irradiation of carcinoma of the bladder over the last 25 years<sup>19</sup>I find external irradiation indicated as an effective primary method of choice in transitional cell carcinomas. This technique is indicated in grade IV carcinomas regardless of the degree of infiltration and in grade III tumors as long as the carcinoma has not massively invaded the muscle (stages A and B1). It has been found to be ineffective as a curative procedure for grade I carcinoma in doses that are tolerated by the bladder wall. As a matter of fact, in some cases studied, microscopic sections of biopsy specimens taken prior to and following treatment of such carcinomas could have been exchanged.<sup>20, Fig 99, 100</sup>Occasionally, however, the response to irradiation may be sufficiently great to achieve temporary regression. Treatment thus may be of a palliative value for elderly patients with
Type of antidepressant is not linked to suicide rates
Journal: BMJ (2003)

able to make true informed choices, support and funding for routine mammography will continue to be questioned. Evidence based interventions can prevent fractures in elderly peopleFractures among elderly people represent an important and preventable public health problem.In a clinical review on the topic, Woolf and Akesson (p 89) state that prevention of fractures involves reducing falls, minimising the morbidity associated with falls, and maximising bone strength at all ages.Pharmacological treatment is most cost effective for people at high risk: women, people over 75 years old, and elderly patients with osteoporosis or previous falls.Frailty and comorbidity are also associated with risk of fractures.The authors outline a selective case finding approach to help clinicians recognise and treat elderly patients at risk.
Special Communication
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Doctor as patient advocate
Authors: W. S. Hotchkiss
Journal: JAMA (1987)

I come before you tonight with feelings of pride, humility, enthusiasm, resolve, and deep respect. I respect the many outstanding physicians who have led the AMA before me, and each of you for your selfless commitment in working on behalf of the health of the American people. But most of all, I respect the institution of medicine and what it stands for—health, dignity, service, and excellence. For more than 100 years, the AMA has dedicated itself to preserving those fundamental ideals of American medicine, and I'm proud to be a part of that tradition. I like to remind people that the AMA is a caring organization of service to the American people. As physicians, we are not here to do battle with the government for our self-interests, we are not here to become leaders of corporate America, and we are certainly not here to amass wealth; we are here for
Spooner syndrome
Authors: S. Waisrub
Journal: JAMA (1977)

'Tis no secret that physicians can be killjoys. Most of the things that are fun in life turn out to be bad for your health. Witness the exhortations not to smoke vile cigarettes, not to eat rich foods, and not to drink heady wines. Less well known is the joy-jading effect of medical diagnosis on our cherished beliefs. One such belief is that spoonerisms—the seemingly accidental, funny interchanges of first syllables or sounds of words—are anything but deliberate comic inventions. William Archibald Spooner (1844 to 1930), dean of New College, Oxford, was credited with originating spoonerisms when he preached on "Kinquering Congs." Few at the time would have suspected the respected dean of suffering from a cerebral disorder, certainly none of his contemporary Oxford wits who imitated him. And one can be sure that no such thought entered the mind of the vaudevillian who confessed to being "under the affluence
Public Health Investigations of Hazardous Organic Chemical Waste Disposal in the United States
Authors: Robert Levine, Dale D. Chitwood
Journal: Environmental Health Perspectives (1985)

Despite marked national concern, the number of published public health investigations of organic chemical hazardous wastes is small. Moreover, the extant literature provides little or no convincing evidence, either positive or negative, as to the question whether waste sites are harmful to human health. In this review, available literature is characterized as to time, place, and person. The majority of studies began 2 years or more after the end of exposure and 10 years after the start of exposure. Vast geographic areas of exposure have never been investigated. The number of study subjects evaluated has generally been too small to detect rare but important effects. The most common determinant of sites chosen for investigation has been the concern of local citizen groups. Several hypotheses are advanced to explain this pattern: methodologic and logistic difficulties; extensive litigation surrounding many waste sites; governmental reorganization which transferred environmental health from public health authority in the 1970s; and the presence of forces which have worked to block active community diagnosis.